Table 1.
NLR ≤ 4 n = 51 |
NLR > 4 n = 20 |
P-value | |
---|---|---|---|
Age | |||
Years of age, median (IQR) | 55 (49–58) | 55 (49–59) | 0.9a |
Sex | |||
Males, n (%) | 42 (82%) | 11 (55%) | 0.021 b |
Prior Therapy, n (%) | |||
Nephrectomy | 51 (100%) | 20 (100%) | - |
Previous systemic treatment | 7 (14%) | 6 (30%) | 0.12b |
Number of metastatic disease sites, n (%) | |||
1 | 11 (22%) | 6 (30%) | 0.40c |
2 | 15 (29%) | 2 (40%) | |
3 | 12 (24%) | 5 (25%) | |
≥ 4 | 13 (26%) | 7 (35%) | |
IMDC risk factors, n (%) | |||
Favorable | 7 (14%) | 2 (10%) | 0.013 c |
Intermediate | 39 (76%) | 10 (50%) | |
Poor | 5 (10%) | 8 (40%) |
aWilcoxon Rank Sum
bChi-Square
cFisher’s Exact
Italicized values are less than 0.05